162 MEK162 (ARRY-162), a novel MEK 1/2 inhibitor, inhibits tumor growth regardless of KRas/Raf pathway mutations
| Autor: | Winski, S., Anderson, D., Bouhana, K., Impastato, R., Woessner, R., Zuzack, J., Tunquist, B., Garrus, J., Pheneger, T., Lee, P. |
|---|---|
| Zdroj: | In EJC Supplements 2010 8(7):56-56 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect